1 / 3
                            TB - Free Philippines

Long term goal (2035)

Reduce TB burden by decreasing TB mortality rate by 95% and TB incidence by 90%.

Medium term goals (2022):

Reduce TB burden by:
  • Decreasing the number of TB deaths by 50% from 14,000 to 7,000
  • Decreasing TB incidence rate by 25% from 322 / 100,000 to 243/ 100,000
Reduce catastrophic costs incurred by TB-affected households from ____ to zero. (baseline data will be available by Q2 2017 from the ongoing catastrophic study)

At least 90% of patients are satisfied with the services of the DOTS facilities.

Specific objectives by 2022

  1. Improve the utilization of TB care and prevention services by patients and communities.
  2. Reduce catastrophic cost of TB-affected households accessing DOTS facilities to zero.
  3. Ensure adequate and competent human resources for TB elimination efforts.
  4. Improve the use of TB data for effective TB elimination efforts.
  5. Guarantee that all TB diagnostic and DOTS facilities are complying with NTP standards and with adequate quality NTP products.
  6. Increase to at least 90% of DOTS facilities that are providing integrated patient centered TB care and prevention services
  7. Enhance the capacities of all LGUs to implement localized TB elimination plan in coordination with different sectors

What's New?

• ONLINE SURVEY for PMDT Healthstaff:

​The Philippines National Tuberculosis Program (NTP), with the support of TREAT TB, is conducting an assessment of the NTP’s Supervision, Monitoring and Evaluation system (SME system) – particularly as it relates to programmatic management of drug-resistant TB (PMDT). The goal of the assessment is to understand the strengths, weaknesses, and gaps of the SME system, so that the NTP can improve the impact of monitoring, evaluation and supervision activities.

This survey is being conducted as part of the NTP’s assessment, to understand the SME system and activities undertaken at your office/facility, as well as to solicit your feedback on how to improve the functioning of the system and the support provided to you by national and regional offices of the NTP.

Your responses will be confidential and we will not collect identifying information from you that will allow us to connect your answers to you. We will store all survey answers in a manner appropriate to protect your confidentiality.

Your survey responses will be used by the NTP only in connection with the SME assessment.

If you have any questions about the survey or the SME assessment, please contact Melvin B. Marzan at mmarzan@treattb.org.

Note: Technology, Research, Education, and Technical Assistance for Tuberculosis (TREAT TB) is a multiyear project funded by USAID that seeks to contribute to new knowledge through field evaluations of diagnostic tools, clinical trials of priority research questions, and targeted operational research benefiting global, regional, and country TB control efforts.

 Survey Link

•  DEADLINE EXTENDED: Request for Proposal to Study Quality of Tuberculosis Care in the Philippines.

Although significant progress has been made to eliminate TB as a public health burden, TB still remains one of the leading causes of morbidity and mortality from an infectious disease. For instance, 1.8 million people die from TB in developing countries every year and approximately one quarter of HIV related deaths are due to TB. Despite the substantial progress made to achieve a world free of TB, WHO estimates that almost 3 million cases are missed each year – not diagnosed, treated or reported to National TB Programs. Additionally, the rapid emergence of multi-drug resistant TB (MDR-TB) has the potential of reversing the two decades of progress mitigating the impact of TB.

 Read More

•  DEADLINE EXTENDED: Call for Stop TB Partnership's 2017 Kochon Prize nominations for TB researchers and developers.

Write-up: The 2017 Kochon Prize recognize and pay tribute to the people and organizations who dare to push the scientific boundaries and reach for the targets set forth in the Global Plan to End TB and the End TB Strategy. The application period is now open and should be sent to the Stop TB Partnership no later than Monday, 18 December 2017 at 18:00 (Geneva time).

 Read More

End TB News

 Click Here To Go to End TB News Page
Uploaded: September 3, 2017
•  President Duterte signs the Occupational Safety and Health Standards Act (Republic Act 11058)

For the health aspects of the Act, the focus is on tuberculosis, hepatitis and HIV. Here is a nice DOLE-primer, although a little outdated:   http://bit.ly/2N7a8I1. DOLE is now in the process of writing the "implementing rules and regulations" for this Act. Engaging DOLE and the formal sector for health in the context of this new Act will help us to reach out to almost 26% of the general population who are in the formal sector.

  Here is Republic Act 11058, drafted in 2017 and signed in 2018

•   The Global Laboratory Initiative (GLI) announces the launch of the Specimen Referral Toolkit

This toolkit is for developing, strengthening and integrating specimen referral networks globally.

 Read More

•   WHO Bulletin: Patient-led active tuberculosis case-finding in the Democratic Republic of the Congo

Volunteers, mostly ex-TB patients, screened 650,000 people at the cost of US$0.29 per person screened and US$ 44 per person diagnosed. The intervention resulted in an additional 4,300 sputum-smear-positive pulmonary tuberculosis diagnoses, 42% (4,300/10,247) of the provincial total for that period.

 Read More

•   WHO publishes updated and consolidated guidelines on Latent TB Infection

This new guideline mentions that National TB Programs need to focus on TB contacts who are above five-year of age too, and not just under-five contacts and PLHIV. It recommends shorter regimens to treat Latent TB Infection, e.g., INH + Rifampicin daily for three months and INH + Rifapentine weekly for three months.

 Read More

•   Lancet: Chest radiography may be offered to people living with HIV who are on ART in addition to four-symptom screening

The systematic review suggests that the WHO’s four-symptom screening rule has lower sensitivity among people with HIV (PLHIV) who are on ART. Hence, chest radiography may be offered to PLHIV who are on ART to improve the sensitivity of the four-symptom screening rule, provided it does not pose a barrier to preventive treatment. The WHO guideline on Latent TB Infection (above) mentions this too.

 Read More

•   USAID/CTB publishes TB Stigma Measurement Guidance

This is a technical guide to help TB programs and partners measure levels of TB stigma in specific settings and populations.

 Read More

Information Resources

NTP Manual of Procedures 5th Edition
NTP Dowloadable Forms

Related Links


Gallery News Clips

 Click Here To Gallery News Clips Page
Uploaded: April 2, 2017
• NTP Holds its 1st National Consultative Planning for 2017.

The National TB Control Program conducted its first National Consultative Planning (NCP) last February 7-10, 2017 at Bali Village Hotel Resort and Kubo Spa, Tagaytay City. This has been a back-to-back activity with the National AIDS/STI Prevention and Control Program (NASCP) in the conduct of its operational planning with the regional coordinators for HIV Strategic Plan 2018-2022.
 Read More

• PBSP Hosts the PMDT Data Quality Check and Plan Enhancement Workshop.

Philippine Business for Social Progress (PBSP) takes the lead in organizing the five batches of the PMDT Data Quality Check and Plan Enhancement Workshop which ran from January 16 to February 2, 2017.
 Read More

• KNCV-HIVOS Project Kick-Off

The Netherlands Ministry of Foreign Affairs Project entitled: “Making the Global Fund Money Work” was launched in the Philippines last January 12-13, 2017 at Pan Pacific Hotel, Malate Manila. This is a five year project synced with USAID Challenge TB (CTB) program and Global Fund to Fight AIDS, Tuberculosis and Malaria.
 Read More

Be Part of Our Team

 Learn More

Number of Visitors



Source: ITIS Approved Report (Regional Level)


Registered DS and DR TB Cases for the Year 2017


DOTS Facilities as of this Year


NTP Laboratories as of this Year